Enter assignee name

EPO Patents = 5

Trademarks = 1

Forward Citations = 58

Loading Chart...

4 inventors (with patents filed for the assignee):

Peter Ruppersberg (12 out of 30 patents)

Philip Haeusser (3 out of 9 patents)

Peter Jacobs (1 out of 9 patents)

4. David Emanuel Lukŝic (1 out of 3 patents)

5. David Emanuel Luksic (0 patent)

6. Lukas Tenbrink (0 patent)

7. Kostiantyn Serhiyovich Ahapov (2 patents)

8. Melissa Huang Szu-Min Kong (2 patents)

12 patents: Sort by Forward Citations

1. 11839445 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2023-12-12),

2. 11672465 - Methods, systems, devices, and components for visualizing electrographic flow (EGF) (2023-06-13),

3. 11523762 - Electrophysiological mapping catheter (2022-12-13),

4. 11484239 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2022-11-01),

5. 11471114 - Medical system for mapping of action potential data (2022-10-18),

6. 11389102 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2022-07-19),

7. 10980418 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2021-04-20),

8. 10888391 - Optical force sensing assembly for an elongated medical device (2021-01-12),

9. 10888236 - System for analyzing electrophysiological data and method for analyzing electrophysiological data (2021-01-12),

10. 10813590 - Electrophysiological mapping catheter (2020-10-27),

11. 10201277 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2019-02-12),

12. 10143374 - Systems, devices, components and methods for detecting the locations of sources of cardiac rhythm disorders in a patient's heart (2018-12-04),

Ablacon Inc. is a medical technology company based in Wheat Ridge, Colorado, specializing in advanced solutions for cardiac arrhythmias. The organization focuses on developing innovative devices and software aimed at improving the diagnosis and treatment of heart rhythm disorders. With a commitment to enhancing patient outcomes, Ablacon leverages cutting-edge research in electrophysiology and data analytics to create tools that assist healthcare professionals in delivering precise and effective care.

Profile summary based on public USPTO records.